InflaRx N.V. Stock Price (IFRX)

Key Statistics

Open
Previous Close
Bid
Ask
Day Range -
52 Week Range -
Volume
Avg. Volume
Volume to USD
Market Cap
Beta
PE Ratio
Latest EPS
EPS TTM
Dividend
Dividend Yield
Ex-Dividend Date
Revenue TTM
Revenue per Share
Revenue per Employee
Profit Margin
Gross Profit TTM
Total Cash TTM
Total Debt TTM

Share Distribution

Shares Outstanding
Float
Short Interest
Short Ratio
Insider Ownership
Institution Ownership

Latest Headlines

Coloplast (CLPBY) Presents At BofAML Global Healthcare Conference - SlideshowFri, 20 Sep 2019 11:14:15 UTC via Seeking Alpha
AI Healthcare Technology Could Boost “AIIQ” ETFThu, 19 Sep 2019 10:43:16 UTC via ETF Trends
Incyte Corporation (INCY) Presents At Bank of America Merrill Lynch Global Healthcare Conference - SlideshowThu, 19 Sep 2019 10:11:26 UTC via Seeking Alpha
Viemed Healthcare (VMD) Investor Presentation - SlideshowWed, 18 Sep 2019 15:02:31 UTC via Seeking Alpha
Amgen Inc. (AMGN) Management Presents at The Bank of America Merrill Lynch Global Healthcare Conference (Transcript)Wed, 18 Sep 2019 09:01:33 UTC via Seeking Alpha
Waters Corp.: A Unique Healthcare BetWed, 18 Sep 2019 08:52:45 UTC via Seeking Alpha
American Renal's Share Appreciation Ignores The Risks Of A Changing Healthcare SystemMon, 16 Sep 2019 09:00:00 UTC via Seeking Alpha
Cardiovascular Systems (CSII) Presents At Morgan Stanley 17th Annual Global Healthcare Conference - SlideshowFri, 13 Sep 2019 15:14:49 UTC via Seeking Alpha
BioMarin Pharmaceutical (BMRN) Presents At Morgan Stanley 17th Annual Global Healthcare Conference - SlideshowFri, 13 Sep 2019 11:58:14 UTC via Seeking Alpha
Fact check: Did VP Biden say Americans would have to 'buy in' to his healthcare plan?Thu, 12 Sep 2019 23:06:50 UTC via MSNBC

InflaRx N.V. Performance

5 Day Change 1 Month Change 30 Day Change 3 Month Change 90 Day Change 6 Month Change 180 Day Change Year to Date Change 1 Year Change 2 Year Change 5 Year Change

Active Alerts for IEX:IFRX

You don't have any alerts set for IEX:IFRX.

About InflaRx N.V.

InflaRx NV is a biopharmaceutical company. It discovers and develops potent and specific inhibitors of the complement activation factor known as C5a.

CEONiels Riedemann IndustryBiotechnology SectorHealthcare Websitehttp://www.inflarx.com Issue ExchangeNasdaq Global Select Issue TypeUnknown

Real-time IFRX to USD Trade Analysis on IEX

Market Status Afterhours

Analysis is available when the exchange & market are open.